CRNX EBITDA
Crinetics Pharmaceuticals Inc · EBITDA
CRNX EBITDA
Latest reported-$508.79Mperiod ending
CRNX EBITDA (-$5.95M → -$508.79M)
Annual EBITDA
High-resolution chart · PNG
CRNX ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -461,247,000 | |
| -295,623,000 | |
| -213,431,000 | |
| -162,935,000 | |
| -106,719,000 | |
| -74,005,000 | |
| -52,945,000 | |
| -28,239,000 | |
| -8,999,000 | |
| -5,952,000 |